Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Oct
23
2015
FDA’s Office of Planning Issues Report on Review Process for Combination Products Covington & Burling LLP
Feb
13
2016
CMA Fines GlaxoSmithKline and Several Generic Companies £45 million for Delaying Market Entry of Generic Paroxetine in the UK Covington & Burling LLP
Feb
22
2016
The UK Psychoactive Substances Act 2016: An Example of Poor Drafting and Unintended Consequences for Food? Covington & Burling LLP
Aug
5
2016
FDA Finalizes General Wellness Guidance Covington & Burling LLP
Oct
17
2016
Italy’s AGCM Market Competition Authority Fines Aspen EUR 5 Million for Excessive Pricing Covington & Burling LLP
Dec
8
2016
UK Competition and Markets Authority Imposes Record Fine on Pfizer Covington & Burling LLP
Apr
30
2017
The Week Ahead in the European Parliament – April 28, 2017 Covington & Burling LLP
Jul
26
2017
Senate Armed Services Committee Directs DoD to Reduce Drug Prices Covington & Burling LLP
Aug
1
2017
The Congressional Agenda for August Covington & Burling LLP
Oct
18
2017
FDA Finalizes Guidance on Medical Product Classification Covington & Burling LLP
Sep
30
2018
The Week Ahead in the European Parliament – September 28, 2018 Covington & Burling LLP
Oct
5
2018
UK Government Issues “No Deal” Brexit Notices for the Food & Beverage Sector Covington & Burling LLP
Oct
22
2018
The European Commission finds no illegal State aid was provided by Luxembourg’s non-taxation of McDonald’s Covington & Burling LLP
Nov
8
2018
Drug Pricing In The New Congress Covington & Burling LLP
May
19
2014
China Restructures Its Medical Device Regulatory System Covington & Burling LLP
Jun
4
2014
China Food & Drug Administration Releases Draft Measures On Unannounced Pharmaceutical Drug Inspections Covington & Burling LLP
Jul
28
2014
FDA Finalizes Guidance on the Evaluation of 510(k) Substantial Equivalence Covington & Burling LLP
Aug
4
2014
Commission Updates EU Medical Devices Borderline Manual Covington & Burling LLP
Sep
22
2014
White House Mobilizes Forces Against Superbug Covington & Burling LLP
Oct
8
2014
EU Consultation on the Development of Criteria to Identify Endocrine Disruptors in Biocidal and Plant Protection Products Covington & Burling LLP
Jan
14
2015
Latest Proposal to Repeal Medical Device Excise Tax Gains Traction Covington & Burling LLP
Mar
3
2015
Details Of The European Commission’s Legal Analysis Of ‘Reverse Patent Settlement Agreements’ Revealed Covington & Burling LLP
Apr
7
2015
CMS Releases New Reimbursement Guidance for Biosimilars Covington & Burling LLP
Jun
12
2015
General Court Confirms Market Exclusivity Rights in CTRS Case Covington & Burling LLP
Jan
8
2016
New EU Novel Foods Regulation: Step Towards Simpler and Faster Procedure? Covington & Burling LLP
Apr
3
2017
The Week Ahead in the European Parliament – March 31, 2017 Covington & Burling LLP
May
5
2017
EU Policy Update, May 2017: Brexit and European Elections; Tech and Digital Single Market; Communication and Media; Energy and Environment; Internal Market and Financial Services; Life Sciences and Healthcare; Trade Policy and Sanctions Covington & Burling LLP
Jun
29
2017
EU Vote on First Borderline Decision Confirms: Cranberry Products Are Not Medical Devices Covington & Burling LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins